Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Sanofi (SNY) Cost of Revenue (2016 - 2026)

Sanofi's Cost of Revenue history spans 16 years, with the latest figure at $3.7 billion for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 20.89% to $3.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $33.1 billion, a 35.71% increase, with the full-year FY2025 number at $15.2 billion, up 7.65% from a year prior.
  • Cost of Revenue hit $3.7 billion in Q1 2026 for Sanofi, down from $15.2 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for SNY hit a ceiling of $15.2 billion in Q4 2025 and a floor of $3.0 billion in Q1 2025.
  • Historically, Cost of Revenue has averaged $5.9 billion across 5 years, with a median of $3.7 billion in 2026.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 256.65% in 2023 and later decreased 9.31% in 2024.
  • Tracing SNY's Cost of Revenue over 5 years: stood at $3.8 billion in 2022, then skyrocketed by 256.65% to $13.6 billion in 2023, then rose by 3.86% to $14.1 billion in 2024, then increased by 7.65% to $15.2 billion in 2025, then tumbled by 75.81% to $3.7 billion in 2026.
  • Business Quant data shows Cost of Revenue for SNY at $3.7 billion in Q1 2026, $15.2 billion in Q4 2025, and $10.9 billion in Q3 2025.